Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of July 2019
Filing Date: July 11, 2019
This filing serves as a cover document to furnish a press release issued on July 10, 2019, to the U.S. Securities and Exchange Commission. The registrant files annual reports under Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts solely as a transmission vehicle for an external press release (Exhibit 99.1) and does not contain embedded financial tables or data points.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. Any such details would be contained within the referenced press release (Exhibit 99.1), which is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or descriptions of unusual items. The document is limited to administrative signatures and exhibit listings.
Investor Verification Checklist
- Review the full text of the press release dated July 10, 2019 (Exhibit 99.1) for specific financial results or strategic updates.
- Verify the content of the press release against the company's most recent Form 20-F for context.
- Confirm the identity of the signatories: Rice Powell (CEO) and Michael Brosnan (CFO).